Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: YABAO PHARM.CORP(600351) the Revenue is 572.92 M (+9.15%);the EBIT is 96.59 M (+27.42%);the EPS is 0.102 (+6.87%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.57B9.15%
----
----
EBIT
0.10B27.42%
----
----
EPS
0.10256.87%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf